SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Airline Discussion Board
JETS 24.18+0.8%4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Art Bechhoefer who wrote (1178)6/25/2020 4:27:23 PM
From: Moonray   of 1868
 
A "good treatment drug and a vaccine," as you noted, are hard to come by. Vaccines can take years before tests show they are safe and effective. Treatments may come earlier, but without thorough testing of random, preferably double blind samples, one may not know for at least several months whether the drug is effective, and for how long.
The most promising vaccine, ironically, is not the much publicized new vaccine under test by Moderna, which could actually be approved in another six months to a year.


Moderna Partners With Catalent For First
100 Million Covid-19 Vaccine Doses In Q3
June 25, 2020

Moderna Inc. ( MRNA) said it entered into a collaboration
with Catalent ( CTLT) for large-scale, commercial man-
ufacturing of its mRNA-based experimental vaccine can-
didate against the novel coronavirus.

As part of the agreement, Catalent will provide vial filling
and packaging, as well as additional staffing at its facility
for the production of an initial 100 million doses of the
vaccine candidate to supply the U.S. market starting in
the third quarter of this year. The companies said that they
are also in talks to secure capacity for continued prod-
uction of hundreds of millions of additional doses.

More at: finance.yahoo.com

o~~~ O
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext